Search clinical trials for: Mild to moderate stage

Total 478585 results

Effector Therapeutics
Medpace, Inc.

Completed

Intravenous Zotatifin in Adults With Mild or Moderate COVID-19 (PROPEL)

Corona Virus Infection

United States
Eli Lilly and Company

Active, not recruiting

A Study of Health Care Use and Costs in Participants With Early Stage Alzheimer's Disease (AD) (GERAS-US)

Alzheimer Disease | Mild Cognitive Impairment

United States
Laval University
Canadian Institutes of Health Research (CIHR)

Completed

Impact of Mild or Moderate Physical Activity and Progression of Subclinical Atherosclerosis (MoMA)

Atherosclerosis

Canada
Philipps University Marburg Medical Center

Completed

An Online Intervention Targeting Depression and Low Reward Sensitivity

Depression Moderate | Depression Mild

Germany
AB Science

Completed

Masitinib in Patients With Mild to Moderate Alzheimer's Disease

Alzheimer Disease

Spain, Bulgaria, Greece, Poland, Romania, Ukraine
Oregon Research Institute

Completed

Pilot Test of Parent-Focused Cannabis-Related Actions and Practices Intervention for Adolescent Marijuana Abuse (CAP)

Cannabis Use Disorder, Mild | Cannabis Use Disorder, Moderate

United States
Shanghai JunTop Biosciences Co., LTD
Sponsor GmbH

Terminated

JT001 (VV116) for the Early Treatment of COVID-19

Mild to Moderate COVID-19

China, Hong Kong
Ablon Skin Institute Research Center
Strata Skin Sciences

Active, not recruiting

Study Evaluating the Efficacy and Safety of TheraClearX on Mitigating Mild to Moderate Acne

Acne

United States
University Hospitals Cleveland Medical Center

Completed

Triamcinolone Acetonide Injections in Mild-to-moderate Chronic Plaque Psoriasis With a Novel Needle-free Drug-delivery System

Psoriasis

United States
Ohio State University Comprehensive Cancer Center

Completed

Gentle Yoga and Dietary Counseling in Improving Physical Function and Quality of Life in Stage I-II Endometrial Cancer Survivors

Obesity | Endometrial Carcinoma

United States
Janssen Research & Development, LLC

Approved for marketing

Pre-approval Access Single Patient Request for Niraparib / Abiraterone Acetate Combination (Nira/AA Combination)

Metastatic Castration-resistant Prostate Cancer

Brazil, Austria, Estonia, Israel, Mexico
Universitaire Ziekenhuizen KU Leuven
European Commission

Completed

European Trial on Enhanced DNA Repair Inhibition in Ovarian Cancer (EUDARIO)

Ovarian Cancer | Fallopian Tube Cancer | Primary Peritoneal Carcinoma

Germany, Belgium, Italy, Austria, France
Dr Saara (Ahmad) Muddasir Khan
University of Karachi

Active, not recruiting

Effects of Saffron and Chamomile in Mild to Moderate Depression

Depression

Pakistan
University of Florida
GlaxoSmithKline

Completed

A Trial of Niraparib in BAP1 and Other DNA Damage Response (DDR) Deficient Neoplasms (UF-STO-ETI-001)

Renal Cell Carcinoma | Mesothelioma | Cholangiocarcinoma | Uveal Melanoma

United States
Ethicon, Inc.

Completed

The EVARREST® Paediatric Mild/Moderate Liver and Soft Tissue Bleeding Study

Hemorrhage | Soft Tissue Bleeding | Hepatic Parenchyma Bleeding

United Kingdom, Belgium
Evelo Biosciences, Inc.

Terminated

A Long-Term Extension Trial in Participants With Atopic Dermatitis Who Participated in Previous EDP1815 Trials

Atopic Dermatitis

United States, Australia, Bulgaria, Canada, Germany, Poland
Danyang Huichuang Medical Equipment Co., Ltd.
First Affiliated Hospital of Chongqing Medical University; Rehabilitation Hospital...

Enrolling by invitation

Efficacy and Safety of Near Infrared Light Therapy for Alzheimer's Disease

Mild to Moderate Alzheimer's Disease

China
University of Bari
University of Dublin, Trinity College

Completed

Evaluation of Excellence in Italy's Residence for Execution of Security Measure (ITAL-EE-REMS)

Recovery | Mental Disorder | Schizophrenia and Related Disorders | Intellectual Disability, Mild to Moderate | Personality Disorders and Disturbances in Behavior | Personality Disorders, Antisocial

Italy
Reistone Biopharma Company Limited

Active, not recruiting

Evaluate the Efficacy and Safety of Topical SHR0302 Ointment in Patients With Mild-to-Moderate Atopic Dermatitis (MARBLE-23)

Atopic Dermatitis

China
Institut de Recherches Cliniques de Montreal

Completed

Prevention of Mild-to-moderate Hypoglycemia in Type 1 Diabetes (REVERSIBLE)

Type 1 Diabetes

Canada
Bayer

Completed

A Study to Learn How the Study Treatment Asundexian Moves Into, Through and Out of the Body, How it Works, How Safe it is, and How it Affects the Body in Participants With Mild or Moderate Reduction of Liver Function Compared to Participants With Normal Liver Function

Atrial Fibrillation | Hepatic Impairment | Acute Myocardial Infarction | Prevention of Thromboembolic Events | Non-cardioembolic Ischemic Stroke

Germany
Amgen

Completed

A Study to Evaluate the Pharmacokinetics of Avacopan (CCX168) in Participants With Mild or Moderate Hepatic Impairment

Hepatic Impairment

United States
Portola Pharmaceuticals
Merck Sharp & Dohme LLC

Completed

A Study to Determine the Pharmacokinetics, Pharmacodynamics, and Tolerabiltiy of Betrixaban in Patients With Mild, Moderate, and Severe Renal Impairment

Renal Impairment

Germany
Athira Pharma

Enrolling by invitation

Open Label Study of ATH-1017 for Treatment of Mild to Moderate Alzheimer's Disease

Alzheimer Disease

United States, Australia
Alexion

Completed

Phase 1 Study of ALXN1840 on the Metabolism of a CYP2C9 Substrate in Healthy Participants.

Wilson Disease

United States
Cognition Therapeutics
National Institute on Aging (NIA)

Completed

Pilot Clinical Study of CT1812 in Mild to Moderate Alzheimer's Disease Using EEG

Alzheimer Disease

Netherlands
Suzhou Kintor Pharmaceutical Inc,

Terminated

A Phase 3 Randomized, Double-Blind Placebo Controlled, Multi-regional Trial to Evaluate the Efficacy and Safety of GT0918 for the Treatment of Mild to Moderate COVID-19 Male Patients

COVID-19

Brazil
Evelo Biosciences, Inc.

Completed

A Study Investigating the Effect of EDP1815 in the Treatment of Mild, Moderate and Severe Atopic Dermatitis

Atopic Dermatitis

United States, Australia, Bulgaria, Canada, Germany, Poland
Portola Pharmaceuticals
Novartis

Terminated

Pharmacokinetics of Elinogrel in Healthy Volunteers and Patients With Mild, Moderate, and Severe Renal Impairment

Renal Impairment

United States
Medical University of Vienna

Completed

Efficacy of Edupression.Com® in Depressive Patients (eFICASY)

Depressive; Episode, Major | Recurrent Depressive Disorder, Current Episode Moderate | Recurrent Depressive Disorder, Current Episode Mild

Austria
KoBioLabs

Withdrawn

A Study to Investigate Efficacy and Safety of KBL697 in Patients With Mild to Moderate Active Ulcerative Colitis

Ulcerative Colitis

Australia
University of Medicine and Pharmacy at Ho Chi Minh...

Completed

Comparison of Quality of Life After Discharge of the Mild and Moderate COVID-19 Patients With or Without Herbal Medicine

Quality of Life | COVID-19 Pandemic

Vietnam
Hoffmann-La Roche
Atea Pharmaceuticals, Inc.

Terminated

A Six-Month Follow-Up Study of Participants With Coronavirus Disease 2019 (COVID-19) Previously Enrolled in a RO7496998 (AT-527) Study (MEADOWSPRING)

COVID-19 | Long COVID

Denmark, Switzerland, Turkey, Belgium, Mexico, Brazil, Argentina, Germany, Romania, Ukraine
University of North Carolina, Chapel Hill

Completed

Ultrabrief Behavioral Activation for Reducing Alcohol Use (UBA)

Alcohol Use Disorder, Mild | Alcohol Use Disorder, Moderate

United States
Novartis Pharmaceuticals

Completed

Pharmacokinetic (PK) and Safety Study of Iptacopan (LNP023) in Participants With Mild, Moderate, and Severe Hepatic Impairment Compared to Matched Control Healthy Participants With Normal Hepatic Function.

Hepatic Impairment

United States
Healthcare Innovation Technology Lab
Curio Digital Therapeutics, Inc.

Active, not recruiting

Curio Digital Therapy for the Treatment of Post-partum Depression (SuMMER)

PostPartum Depression

United States
Arcutis Biotherapeutics, Inc.

Completed

Pharmacokinetics (PK), Safety, Efficacy and Maximal Use PK of ARQ-151 in Adolescents/Children With Mild/Moderate Eczema

Atopic Dermatitis (Eczema)

United States
Cybin Therapeutics Inc.

Withdrawn

Effect of SSRIs on Response to Psilocybin Therapy

Depressive Disorder | Depression | Major Depressive Disorder | Moderate Depression | Mild Depression

Canada
Shanghai Vinnerna Biosciences Co., Ltd.
Sponsor GmbH

Completed

JT001 (VV116) for the Treatment of COVID-19

Mild to Moderate COVID-19

China
ClinOhio Research Services, LLC
Arctiva Wellness LLC

Completed

Pilot Study to Test the Effects of Arctiva on Mild to Moderate Eczema

Atopic Dermatitis Eczema

United States
Ipsen

Terminated

Effect of EGb 761® on Patients With Mild to Moderate Alzheimer's Disease

Alzheimer Disease

France
Yasemin ASLAN KELEŞ
Istanbul University - Cerrahpasa (IUC)

Completed

Intradialytic High-Intensity Interval Training in Hemodialysis Patients

End Stage Renal Disease | Exercise, Compulsive

Turkey
BenevolentAI Bio

Completed

A First-in-Human PoC Study With BEN2293 in Patients With Mild to Moderate Atopic Dermatitis

Atopic Dermatitis

United Kingdom
Shin Poong Pharmaceutical Co. Ltd.

Completed

The Efficacy and Safety of Pyramax in Mild to Moderate COVID-19 Patients (Phase3)

COVID-19

Korea, Republic of, Colombia, Argentina, Poland, Chile, United Kingdom
Shenzhen Kexing Pharmaceutical Co., Ltd.

Completed

Study of SHEN26 Capsule in Patients With Mild to Moderate COVID-19

COVID-19

China
Athira Pharma
National Institute on Aging (NIA)

Completed

A Study of ATH-1017 in Mild to Moderate Alzheimer's Disease (ACT-AD)

Alzheimer Disease | Dementia of Alzheimer Type

United States, Australia
LEO Pharma
Bayer

Completed

A Study of Azelaic Acid (AzA) 15% in Topical Treatment of Mild to Moderate Perioral Dermatitis

Perioral Dermatitis

Germany
LEO Pharma
Bayer

Completed

Comparison of Efficacy and Safety of Azelaic Acid 15% Gel With Its Vehicle in Subjects With Mild to Moderate Acne

Acne Vulgaris

United States
Sanofi

Completed

A Pharmacokinetic and Tolerability Study of Fexinidazole in a Single Oral Dose in Adult Participants With Mild and Moderate Hepatic Impairment

Hepatic Function Abnormal

Bulgaria, France
University of Medicine and Pharmacy at Ho Chi Minh...

Completed

Efficacy Evaluation of Shen Cao Gan Jiang Tang on Mild and Moderate COVID-19 Patients

COVID-19 Respiratory Infection | Herbal Medicine

Vietnam

Search clinical trials for: Mild to moderate stage

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Indonesia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations